US90337L1089
US90337L1089
U.S. Physical Therapy, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 1.26B EUR | 1.02B EUR | 1.14B EUR | 1.18B EUR |
Enterprise Value | 1.92B EUR | 1.39B EUR | 1.48B EUR | 1.46B EUR |
Valuation Multiples | ||||
Trailing P/E | 470.39x | -- | -- | 522.53x |
Forward P/E | 25.27x | -- | -- | -- |
Price to Sales | 1.57x | 1.26x | 1.44x | 1.98x |
Price to Book | 2.82x | 2.28x | 2.43x | 2.48x |
EV/Revenue | 2.39x | 1.71x | 1.86x | 2.45x |
EV/EBITDA | 18.86x | 13.39x | 14.1x | 17.45x |
Price to FCF (P/FCF) | 30.6x | 16x | 17.12x | 17.31x |
EV/FCF | 46.59x | 21.63x | 22.14x | 21.4x |
FCF Yield | 3.27% | 6.25% | 5.84% | 5.78% |